On April, 2021, FuturedMe had report the research results to the preprint server bioRxiv.

April 23, 2021 The research team of Etsuko Miyamoto-Sato, a professor at the Tokyo University of Science Research Institute, who is also a director of our company, created a compound that induces the degradation of mutant KRAS using chemical knockdown technology. We confirmed the effectiveness in vivo and reported the research results to bioRxiv.